BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8436441)

  • 1. Granulocyte-macrophage colony-stimulating factor stimulates the metastatic properties of Lewis lung carcinoma cells through a protein kinase A signal-transduction pathway.
    Young MR; Lozano Y; Djordjevic A; Devata S; Matthews J; Young ME; Wright MA
    Int J Cancer; 1993 Feb; 53(4):667-71. PubMed ID: 8436441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the protein kinase a signal transduction pathway by granulocyte-macrophage colony-stimulating factor or by genetic manipulation reduces cytoskeletal organization in Lewis lung carcinoma variants.
    Young MR; Charboneau S; Lozano Y; Djordjevic A; Young ME
    Int J Cancer; 1994 Feb; 56(3):446-51. PubMed ID: 8314333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of the metastatic properties of Lewis-lung-carcinoma cells by autologous granulocyte-macrophage colony-stimulating factor.
    Young MR; Lozano Y; Coogan M; Wright MA; Young ME; Bagash JM
    Int J Cancer; 1992 Feb; 50(4):628-34. PubMed ID: 1537628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of tumor production of granulocyte-macrophage colony-stimulating factor by 1 alpha, 25-dihydroxyvitamin D3 reduces tumor motility and metastasis.
    Young MR; Halpin J; Hussain R; Lozano Y; Djordjevic A; Devata S; Matthews JP; Wright MA
    Invasion Metastasis; 1993; 13(4):169-77. PubMed ID: 8034438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to colony-stimulating factors block Lewis lung carcinoma cell stimulation of immune-suppressive bone marrow cells.
    Young MR; Wright MA; Young ME
    Cancer Immunol Immunother; 1991; 33(3):146-52. PubMed ID: 1675153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of protein kinase A activation and prostaglandin E2-stimulated migration of Lewis lung carcinoma clones.
    Young MR; Young ME; Lozano Y; Coogan M; Bagash JM
    Int J Cancer; 1991 Aug; 49(1):150-5. PubMed ID: 1651907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1 alpha,25-dihydroxyvitamin D3 plus gamma-interferon blocks lung tumor production of granulocyte-macrophage colony-stimulating factor and induction of immunosuppressor cells.
    Young MR; Halpin J; Wang J; Wright MA; Matthews J; Pak AS
    Cancer Res; 1993 Dec; 53(24):6006-10. PubMed ID: 8261414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Lewis lung carcinoma invasion and metastasis by protein kinase A.
    Young MR; Montpetit M; Lozano Y; Djordjevic A; Devata S; Matthews JP; Yedavalli S; Chejfec G
    Int J Cancer; 1995 Mar; 61(1):104-9. PubMed ID: 7705921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein phosphatases limit tumor motility.
    Young MR; Lozano Y; Djorjevic A; Maier GD
    Int J Cancer; 1993 Jul; 54(6):1036-41. PubMed ID: 8392979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of tumor invasiveness by 1alpha,25-dihydroxyvitamin D3 coupled to a decline in protein kinase A activity and an increase in cytoskeletal organization.
    Young MR; Lozano Y
    Clin Exp Metastasis; 1997 Mar; 15(2):102-10. PubMed ID: 9062386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of protein kinase A increases the in vitro invasion, migration, and adherence to reconstituted basement membrane by Lewis lung carcinoma tumor cells.
    Young MR; Young ME; Lozano Y; Bagash JM
    Invasion Metastasis; 1992; 12(5-6):253-63. PubMed ID: 1298738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of a functional prostaglandin E2-protein kinase A coupling with responsiveness of metastatic Lewis lung carcinoma variants to prostaglandin E2 and to prostaglandin E2-producing nonmetastatic Lewis lung carcinoma variants.
    Young MR; Duffie GP; Lozano Y; Young ME; Wright MA
    Cancer Res; 1990 May; 50(10):2973-8. PubMed ID: 2159367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing infiltration and activation of CD8+ tumor-infiltrating lymphocytes after eliminating immune suppressive granulocyte/macrophage progenitor cells with low doses of interferon gamma plus tumor necrosis factor alpha.
    Young MR; McCloskey G; Wright MA; Pak AS
    Cancer Immunol Immunother; 1994 Jan; 38(1):9-15. PubMed ID: 8299123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of serum deprivation on constitutive production of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells.
    Uemura Y; Kobayashi M; Nakata H; Harada R; Kubota T; Taguchi H
    Int J Cancer; 2004 May; 109(6):826-32. PubMed ID: 15027115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of immune suppressive CD34+ cells from normal bone marrow by Lewis lung carcinoma tumors.
    Wright MA; Wiers K; Vellody K; Djordjevic D; Young MR
    Cancer Immunol Immunother; 1998 Jul; 46(5):253-60. PubMed ID: 9690453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte-macrophage-colony stimulating factor stimulates tumor invasiveness in squamous cell lung carcinoma.
    Tsuruta N; Yatsunami J; Takayama K; Nakanishi Y; Ichinose Y; Hara N
    Cancer; 1998 Jun; 82(11):2173-83. PubMed ID: 9610697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of GM-CSF and M-CSF on tumor progression of lung cancer: roles of MEK1/ERK and AKT/PKB pathways.
    Uemura Y; Kobayashi M; Nakata H; Kubota T; Bandobashi K; Saito T; Taguchi H
    Int J Mol Med; 2006 Aug; 18(2):365-73. PubMed ID: 16820947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on lung cancer: roles of cyclooxygenase-2.
    Uemura Y; Kobayashi M; Nakata H; Kubota T; Saito T; Bandobashi K; Taguchi H
    Oncol Rep; 2007 Apr; 17(4):955-61. PubMed ID: 17342342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of fyn-associated protein tyrosine kinase activity by macrophage colony-stimulating factor (M-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF).
    Li Y; Chen B
    J Leukoc Biol; 1995 Mar; 57(3):484-90. PubMed ID: 7884321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of Fasl and GM-CSF confers synergistic antitumor immunity in an in vivo model of the murine Lewis lung carcinoma.
    Ho MY; Sun GH; Leu SJ; Ka SM; Tang SJ; Sun KH
    Int J Cancer; 2008 Jul; 123(1):123-33. PubMed ID: 18386791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.